Background: Adiponectin, an adipocyte-derived protein, is known to play a key role in the processes leading to atherosclerosis and coronary artery disease (CAD) through its anti-atherogenic, anti-inflammatory, antioxidative, and anti-apoptotic properties.
In the current study, we have studied the association of two single nucleotide polymorphisms (SNPs) +45 T>G (rs2241766) and +276 G>T (rs1501299) of the adiponectin gene with coronary artery disease (CAD) on an Arab/North-African population from Tunisia. 
Conclusion:
There is no allelic or genotypic association of +45 T>G and +276 G>T of the adiponectin gene with CAD in the Tunisian population.
K E Y W O R D S
adiponectin, coronary artery disease, genetic association, haplotype, single nucleotide polymorphism expression of the cellular adhesion molecules in the endothelium, suppresses the accumulation of lipids and inhibits the transformation of the macrophages into foamy cells, as well as the proliferation of the smooth muscle cells, a succession of phenomena encountered in the initiation and evolution of atherosclerotic lesions. 13 Furthermore, the degree of plasma adiponectin reduction is expected to correlate with the extension, the volume and the complexity of coronary atherosclerotic lesions. [14] [15] [16] The relationship between several genetic variants of the adiponectin gene and the development of CAD or cardiovascular disease has been investigated previously in several populations. Two of the most commonly studied SNPs are a silent T to G substitution in exon 2 (+45T>G) and a G to T substitution in intron 2 (+276G>T).
However, inconsistent findings on the association of these two SNPs, either independently or as a haplotype, have been reported. 17, 18 These two SNPs have been repeatedly found to correlate with CAD: SNP +45T>G [19] [20] [21] [22] or +276G>T, [23] [24] [25] albeit with some controversial study that report no association with CAD and related complications 20,26 which could be due to a difference in ethnic populations.
Consequently, data regarding the association between adiponectin polymorphisms and CAD need further investigation because of the conflicting reported results.
The present case-control study aimed to examine the association of SNPs +45 and +276 in the ADIPOQ gene with coronary artery disease in 277 Tunisian patients with angiographically confirmed CAD, and in 269 age-and gender-matched controls from whom informations regarding most known risk factors for CAD were obtained.
| MATERIAL S AND ME THODS

| Study population
The participants in this study were genetically unrelated Tunisian subjects. The sample included 277 patients with CAD (mean age 
| Gene analysis
Peripheral blood was collected, separated within 1 hour, and the samples were kept at −20°C until analysis. Total genomic DNA was extracted from blood leukocytes-rich interphase layer of EDTA anticoagulated by the proteinase K/salting-out method 28 and was dissolved in nuclease-free water and stored at 4°C pending assay.
+45 T>G and +276 G>T genotype analysis was performed by polymerase chain reaction-restriction fragment length polymorphism analysis using SmaI and BsmI digestion, respectively. 29 The Digested fragments for both studied polymorphisms were separated by electrophoresis on 2.5% ethidium bromide-staining agarose gels and were visualized by UV transillumination.
| Statistical analysis
All statistical analyses were performed using the SPSS for windows version 20.0 software (SPSS, Inc., Chicago IL, USA). Allele frequencies were calculated using the gene-counting method, and both polymorphisms were tested for Hardy-Weinberg's equilibrium using the chi-squared test. Differences in characteristics between CAD patients and control groups were analyzed using the χ 2 test or Student's t test. Baseline characteristics were expressed as mean ± standard deviation, and categorical variables were presented as total number (percentage). For all analysis, results were expressed as P-value, odds ratio (OR), and 95% confidence intervals (CI). Statistical significance level was set at P < .05.
Genotypic associations to CAD presence for dominant, additive,
and recessive genetic models were tested by calculating a logistic regression statistic and corresponding P value using the program SNPstats (http://bioinfo.iconcologia.net/snpstats/start.htm). The results are expressed as P value (two-tailed), odds ratio (OR), and 95% confidence intervals (CI).
Haplotype analysis was performed using a maximum-likelihood method, 30 in which the haplotypes frequencies were expressed as OR (95% CI) for a binary phenotype by comparison with the most frequent haplotype (http://genecanvas.ecgene.net). The significance level was set at P < .05.
| RE SULTS
The clinical characteristics of the 277 CAD patients and 269 control subjects are presented in Table 1 . The two groups were matched for age (P = .38) and gender (P = .69). Significantly higher percentage of hypertensive, diabetic, and smoker individuals were seen in cases (P < .001). Elevated total cholesterol (P < .001), low-density lipoprotein (P < .001), and triglycerides (P < .005) were seen in cases compared with control subjects and mean serum HDL was lower (P < .001) in patients compared to controls. Mean systolic BP and diastolic BP (P < .005) was higher in patients group.
The distribution of 45 T>G and 276 G>T alleles and genotypes was comparable between the healthy and the patient groups. The genotype distributions of these SNPs obeyed Hardy Weinberg equilibrium in the control group. The genotypic distributions were comparable between cases and controls either for +45 T>G (P = .72) or +276 G>T (P = .92) ( Table 3 ).
Haplotype distribution (Table 4) taking +45T/+276G haplotype as reference (OR = 1.00) showed that none of the adiponectin haplotypes was associated with CAD in our study (P = .89). Double mutant haplotype +45G/+276T was present at very low frequencies either in controls (0.03) or patients (0.04).
| D ISCUSS I ON
Previous studies have examined the relationship between adiponectin gene polymorphisms and coronary artery disease in different populations including Europeans, Asians, and Americans.
Although studies on the association between SNPs at +45 (rs2241766) and +276 (rs1501299) loci of adiponectin gene and The aim of the present case-control study was to evaluate the association between these two single nucleotide polymorphisms with the risk of developing CAD on an Arab/North-African population.
TA B L E 1 Characteristics of study participants
Clinical characteristics controls (n = 269) Cases (n = 277) P
Gender M/F n (%)
In our study, similar distributions were observed between patients and controls either for genotype or allelic frequencies for both SNPs +45T>G and +276G>T, so that our data failed to demonstrate any association with development of coronary artery disease in the Tunisian population. Lack of association of the SNP +276
with CAD in our Study is in agreement with some other reports.
Ohashi et al 36 reported that no association has been observed for this SNP and incidence of coronary artery disease in 383 Japanese patients with documented coronary heart disease and 368 healthy controls. Tong et al 37 recently reported that in 1110 subjects with or without CAD in type 2 diabetes (560 CAD patient and 550 control subjects), polymorphism + 276 G>T showed no significant association with coronary artery disease incidence with an odds ratio being 0.83 (0. between the SNP +276G>T and coronary heart disease. In addition, a previous meta-analysis found that the +276G>T polymorphism was associated with a decreased susceptibility to CAD among peoples with T2DM background.
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The finding that the silent mutation +45 T>G (GGT→GGG, Gly15Gly) at exon 2 was not associated with coronary artery disease in our study was previously reported in several studies.
Qi et al, 20 in a survey including 879 diabetic Americans male from the Health Professional Follow-up, failed to find any significant associations between SNP +45 and cardiovascular risk.
Similarly, the same authors did not find any significant associa- [42] [43] [44] Concerning the association of the haplotypes comprised of the two common SNPs +45T>G and +276G>T, we did not found a significant association between any haplotype and CAD. Our findings are in agreement with some other studies. Pischon T 34 found no significant difference in the frequency of haplotypes defined by the 5 adiponectin SNPs studied. Furthermore, in the same study, haplotype analysis revealed no effect on the development of CHD among white men and woman when they used the +45T>G and 
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